Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS

This study analyzes the use of sodium nitroprusside (SN) as an option to reduce blood pressure (BP) below 180/105 mmHg during the management of acute ischemic stroke (AIS) in patients submitted to intravenous thrombolysis.Method The sample was composed by 60 patients who had AIS and were submitted t...

Full description

Saved in:
Bibliographic Details
Published inArquivos de neuro-psiquiatria Vol. 73; no. 9; pp. 755 - 758
Main Authors Koslyk, Jessyca L, Ducci, Renata D, Nóvak, Edison M, Zétola, Viviane F, Lange, Marcos C
Format Journal Article
LanguageEnglish
Published Brazil Academia Brasileira de Neurologia - ABNEURO 01.09.2015
Academia Brasileira de Neurologia (ABNEURO)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This study analyzes the use of sodium nitroprusside (SN) as an option to reduce blood pressure (BP) below 180/105 mmHg during the management of acute ischemic stroke (AIS) in patients submitted to intravenous thrombolysis.Method The sample was composed by 60 patients who had AIS and were submitted to intravenous rtPA, split in two groups: half in the control group (CG) with BP < 180/105 mmHg and half in SN group with BP > 180/105 mmHg. Outcome variables were any hemorrhagic transformation (HT); the presence of symptomatic HT, National Institute of Health Stroke Scale (NIHSS) after 24 hours of treatment; the independence on discharge and death until three months after stroke onset.Results There were no statistical differences between both groups to any of the outcome variables analyzed.Conclusion The SN might be safe for BP control during thrombolysis to AIS.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0004-282X
1678-4227
1678-4227
0004-282X
DOI:10.1590/0004-282X20150104